Literature DB >> 26435950

A Comparative Study of Histopathology of Astrocytomas with Intraoperative Cytology with Special Reference to MIB-1 Labelling Index.

Deepti Sukheeja1, Shashi Singhvi2, Naresh N Rai3, Manojit Midya4.   

Abstract

BACKGROUND: Although radiological imaging and surgical techniques have substantially improved, assessment of prognosis by grading astrocytoma has been challenging task for pathologists. We have tried to assess these tumours intraoperatively for rapid diagnosis. Also MIB-1Labelling index (MIB-1 LI) was done to study their proliferative activity. AIMS: To compare and grade squash smear technique with histopathology to study its utility in diagnosis of astrocytomas. Further, to study correlation of various grades with their MIB-1 labelling index. SETTING AND DESIGNS: This study was carried out in the Department of Pathology, SMS Medical College, Jaipur over a period of one year.
MATERIALS AND METHODS: Forty five cases of radiologically suspected astrocytomas were submitted for intraoperative cytology and later for histopathology. Two techniques were compared for ability to diagnose as well as grade the tumour. Also, MIB-1 LI were performed in biopsy tissue. Histopathological and immunological grades were compared.
RESULTS: Out of 45 cases 44(97.7%) correctly diagnosed by squash smear technique. Further significant differences seen in values of MIB-1 LI of high-grade and low-grade astrocytomas. A progressive increase in the MIB-1 LI was observed with increasing grades. In grade I astrocytoma MIB-1 LI was <0.05%. In grade II astrocytoma it varied from 0.8-2.6% except in one case where it was 3.2% who presented with a recurrent mass. In grade III, MIB-1 LI was 3.5% to 7.5%. In grade IV was 10-20%.
CONCLUSION: Intraoperative cytology is fairly accurate and useful in intraoperative consultation. Also, MIB-1 LI can be a useful adjunct for grading particularly in small biopsies.

Entities:  

Keywords:  Astrocytoma Grading; Proliferative index; Squash smear cytology

Year:  2015        PMID: 26435950      PMCID: PMC4576541          DOI: 10.7860/JCDR/2015/12372.6281

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  8 in total

1.  Practical value of MIB-1 index in predicting behavior of astrocytomas.

Authors:  M Moses Ambroise; Charu Khosla; Mitra Ghosh; V S Mallikarjuna; S Annapurneswari
Journal:  Indian J Pathol Microbiol       Date:  2011 Jul-Sep       Impact factor: 0.740

2.  High diagnostic accuracy of cytologic smears of central nervous system tumors. A 15-year experience based on 4,172 patients.

Authors:  Karl Roessler; Wolfgang Dietrich; Klaus Kitz
Journal:  Acta Cytol       Date:  2002 Jul-Aug       Impact factor: 2.319

3.  Diagnosis of Intracranial Tumors by Supravital Technique.

Authors:  L Eisenhardt; H Cushing
Journal:  Am J Pathol       Date:  1930-09       Impact factor: 4.307

4.  A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.

Authors:  P E McKeever; D A Ross; M S Strawderman; J A Brunberg; H S Greenberg; L Junck
Journal:  J Neuropathol Exp Neurol       Date:  1997-07       Impact factor: 3.685

5.  MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.

Authors:  L Neder; B O Colli; H R Machado; C G Carlotti; A C Santos; L Chimelli
Journal:  Clin Neuropathol       Date:  2004 Nov-Dec       Impact factor: 1.368

6.  Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status.

Authors:  T Moriki; T Takahashi; H Kataoka; M Hiroi; T Yamane; H Hara
Journal:  Pathol Int       Date:  1996-12       Impact factor: 2.534

7.  Cellular proliferation in pilocytic and diffuse astrocytomas.

Authors:  C Giannini; B W Scheithauer; P C Burger; M R Christensen; P C Wollan; T J Sebo; P A Forsyth; C J Hayostek
Journal:  J Neuropathol Exp Neurol       Date:  1999-01       Impact factor: 3.685

Review 8.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

  8 in total
  1 in total

1.  Clinical Evaluation of Proline, Glutamic acid, and Leucine-Rich Protein 1 Expression in Astrocytomas and Correlations with the Proliferation Marker Ki-67.

Authors:  Karthika P Padmavathy; Veena Kumari Vuttaradhi; Akkanapally Venu; Lawrence D'Cruze; Roshni Saravanan; Ravishankar Pitani; Krishnamurthy Ganesh; Himavani Pacharla; Suresh Kumar Rayala; D Prathiba; Ganesh Venkatraman
Journal:  J Mol Neurosci       Date:  2020-09-22       Impact factor: 3.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.